M3 Gross Profit

The latest gross profit for MTHRY is $140B as of June 2026. That compares with $200B in the prior-year period — down 32.7% year over year. That is above the Healthcare sector average of $66B. Investors often review this figure alongside M3's historical trend and sector peers before judging valuation or financial health.

Over the past year, MTHRY's gross profit moved from $200B to $140B — a 32.7% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in M3's operating scale or balance-sheet position.

Against Healthcare companies, MTHRY currently prints $140B for gross profit, while the sector average sits near $66B. That is roughly 108.6% above the sector mean. Large gaps often invite a closer look at M3's growth, margins, and balance sheet.

A gross profit figure of $140B for MTHRY is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $66B. Explore the charts below for those layers of context.

After noting MTHRY's gross profit ($140B), review year-over-year change from $200B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.